regains

GRI Bio (NASDAQ:GRI) has received notice on July 2, 2024, from The Nasdaq that the Co. regained compliance with all applicable Nasdaq listing standards for continued listing on the Nasdaq. “We are very excited about this development and look forward to focusing our efforts on our core business-developing novel product candidatesContinue Reading